节点文献

血清TNF-α、IL-1β、TGF-β1、E-选择素和L-选择素在肾综合征出血热发病机制中的作用

The role of serum TNF-α,IL-1β,TGF-β1,E-selectin and L-selectin in the pathogenesis of hemorrhagic fever with renal syndrome

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张东军孙志坚王锁荣马志俊

【Author】 ZHANG Dongjun,SUN Zhijian,WANG Suorong,et al.Department of Infectious Diseases,City Hospital of Donyang,Donyang 212300,CHINA

【机构】 丹阳市人民医院感染病科南京医科大学第一附属医院感染病科丹阳市人民医院感染病科

【摘要】 目的研究血清肿瘤坏死因子α(TNF-α)、白细胞介素1β(IL-1β)、转化生长因子β1(TGF-β1)、E-选择素和L-选择素在肾综合征出血热(HFRS)发病机制中的作用。方法41例HFRS患者(轻症组22例,重症组19例)接受了研究,按病期采血,分别用放射免疫法和ELISA法检测血清TNF-α、IL-1β、TGF-β1、E-选择素和L-选择素,并同期作肝、肾功能和血常规检查。结果从发热期至多尿期,血清IL-1β、TNF-α、E-选择素、L-选择素均显著升高,与ALT、BUN的变化趋势相一致;与此相反,血清TGF-β1含量、TGF-β1/IL-1β和TGF-β1/TNF-α比值在病程前三期均见降低,与Plt的变化趋势相似。结论HFRS急性期血清IL-1β、E-选择素、L-选择素升高和TGF-β1水平下降是造成失控性全身炎症反应和肝、肾功能损害的重要因素,在HFRS发病机制中起重要作用;合理的对症治疗和适量使用免疫调节剂可望改善本病的预后。

【Abstract】 Objective To evaluate the role of serum levels of soluble tumour necrosis factor-α(TNF-α),interleuleukin-1β(IL-1β),transforming growth factor β1(TGF-β1),E-selectin and L-selectin in the pathogenesis of hemorrhagic fever with renal syndrome(HFRS).Methods Blood samples from 41 HFRS patients(22 of moderate type,19 of severe type) were collected for detecting TNF-α and IL-1β,and ELISA for E-selectin,L-selectin and TGF-β1 by radioimmunoassay.Meanwhile,serum alanine aminotransferase(ALT),blood urea nitrogen(BUN) and platelet count were examined.ResultsDuring the first three stages of HFRS,serum levels of IL-1β,TNF-α,L-selectin and E-selectin were significantly increased,the curves of them were sinilar to those of ALT and BUN.On the contrary,serum TGF-β1 level,TGF-β1/IL-1β ratio,TGF-β1/TNF-α ratio and blood platelet count were significantly decreased in a parallel manner,so did the changes of platelet.Conclusions The increased serum levels of soluble TNF-α,IL-1β,E-selectin and L-selectin associated with a decreased TGF-β1 level might be an important cause leading to uncontrolled systemic inflammatory response and liver-kidney damage,and thus involved in the pathogenesis of HFRS.The combination of reasonably symptomatic therapy with immunomodulator would improve the prognosis of HFRS.

  • 【文献出处】 江苏医药 ,Jiangsu Medical Journal , 编辑部邮箱 ,2007年06期
  • 【分类号】R512.8
  • 【被引频次】2
  • 【下载频次】152
节点文献中: 

本文链接的文献网络图示:

本文的引文网络